|
10:30–12:30
|
BREAKOUT SESSION 1—PREDICTIVE BIOMARKERS FOR NEPHROTOXICITY
Room 206
|
|
Moderators:
|
FRANK SISTARE
Merck Research Laboratories
|
|
|
PRASAD DEVARAJAN
Cincinnati Children’s Hospital Medical Center, University of Cincinnati
|
|
Panelists:
|
JOSEPH BONVENTRE
Harvard Medical School, Brigham and Women’s Hospital
|
|
|
FRANK DIETERLE
Novartis Pharma
|
|
|
ROBERT STAR
National Institute of Diabetes and Digestive and Kidney Diseases
|
|
|
MELANIE BLANK
U.S. Food and Drug Administration
|
|
|
DAVID WARNOCK
University of Alabama at Birmingham
|
|
10:30–12:30
|
BREAKOUT SESSION 2—PREDICTIVE BIOMARKERS FOR HEPATOTOXICITY
Room 201
|
|
Moderators:
|
PAUL WATKINS
University of North Carolina at Chapel Hill
|
|
|
CHRISTINE HUNT
GlaxoSmithKline
|
|
Panelists:
|
JOHN BLOOM
Eli Lilly and Company
|
|
|
MARK AVIGAN
U.S. Food and Drug Administration
|
